- Home
- MOGU vs LEXX Comparison
MOGU vs LEXX Comparison
Compare MOGU & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- LEXX
- Stock Information
- Founded
- MOGU 2011
- LEXX 2004
- Country
- MOGU China
- LEXX Canada
- Employees
- MOGU N/A
- LEXX N/A
- Industry
- MOGU Business Services
- LEXX Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- LEXX Health Care
- Exchange
- MOGU Nasdaq
- LEXX Nasdaq
- Market Cap
- MOGU 17.8M
- LEXX 16.5M
- IPO Year
- MOGU 2018
- LEXX N/A
- Fundamental
- Price
- MOGU $2.26
- LEXX $0.82
- Analyst Decision
- MOGU
- LEXX Strong Buy
- Analyst Count
- MOGU 0
- LEXX 1
- Target Price
- MOGU N/A
- LEXX $4.00
- AVG Volume (30 Days)
- MOGU 4.3K
- LEXX 195.1K
- Earning Date
- MOGU 08-26-2025
- LEXX 07-14-2025
- Dividend Yield
- MOGU N/A
- LEXX N/A
- EPS Growth
- MOGU N/A
- LEXX N/A
- EPS
- MOGU N/A
- LEXX N/A
- Revenue
- MOGU $19,462,964.00
- LEXX $615,923.00
- Revenue This Year
- MOGU N/A
- LEXX $38.85
- Revenue Next Year
- MOGU N/A
- LEXX $24.13
- P/E Ratio
- MOGU N/A
- LEXX N/A
- Revenue Growth
- MOGU N/A
- LEXX 49.85
- 52 Week Low
- MOGU $1.81
- LEXX $0.78
- 52 Week High
- MOGU $3.14
- LEXX $4.38
- Technical
- Relative Strength Index (RSI)
- MOGU 48.27
- LEXX 40.94
- Support Level
- MOGU $2.12
- LEXX $0.78
- Resistance Level
- MOGU $2.41
- LEXX $0.86
- Average True Range (ATR)
- MOGU 0.16
- LEXX 0.05
- MACD
- MOGU 0.01
- LEXX -0.01
- Stochastic Oscillator
- MOGU 35.96
- LEXX 27.30
About MOGU MOGU Inc. (each representing 25)
MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.